Feb 5 (Reuters) - C-Mer Medical Holdings Ltd 3309.HK:
SEES ADJUSTED EBITDA TO BE AROUND HK$300 MILLION FOR YEAR
SEES REVENUE TO BE AROUND HK$1,900 MILLION IN FY2024
EXPECTED RESULT DUE TO WEAKER THAN EXPECTED PERFORMANCE OF CERTAIN HOSPITALS AND CLINICS
SEES PROFIT ATTRIBUTABLE TO BE WITHIN HK$50 MILLION TO HK$60 MILLION FOR FY
Further company coverage: 3309.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.